Anixa Biosciences
ANIX
ANIX
58 hedge funds and large institutions have $17.6M invested in Anixa Biosciences in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.06% more ownership
Funds ownership: 17.39% → 17.45% (+0.06%)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
Holders
58
Holding in Top 10
–
Calls
$126K
Puts
$24K
Top Buyers
| 1 | +$140K | |
| 2 | +$66.5K | |
| 3 | +$66.2K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$60K |
| 5 |
LNWTC
Laird Norton Wetherby Trust Company
Seattle,
Washington
|
+$52K |
Top Sellers
| 1 | -$206K | |
| 2 | -$50.5K | |
| 3 | -$45.1K | |
| 4 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$40.7K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$38.8K |